DICYNONE 250MG/2ML SOLUTION FOR INJECTION

País: Chipre

Idioma: griego

Fuente: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Ingredientes activos:

ETAMSILATE

Disponible desde:

OM PHARMA SA, LISBOA, PORTUGAL (0000007737) RUA DA INDUSTRIA 2, QUINTA GRANDE, AMADORA, 2610-088

Código ATC:

B02BX01

Designación común internacional (DCI):

ETAMSYLATE

Dosis:

250MG/2ML

formulario farmacéutico:

SOLUTION FOR INJECTION

Composición:

ETAMSILATE (0002624444) 125MG

Vía de administración:

INTRAMUSCULAR USE; INTRAVENOUS USE

tipo de receta:

Εθνική Διαδικασία

Área terapéutica:

ETAMSYLATE

Resumen del producto:

Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 4 AMPS x 2ML (850051601) 4 AMPOULE - Εγκεκριμένο - Με Ιατρική Συνταγή

Información para el usuario

PACKAGE LEAFLET
PACKAGE LEAFLET: INFORMATION FOR THE USER
DICYNONE 250
Etamsylate
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
USING
THIS
MEDICINE
BECAUSE
IT
CONTAINS
IMPORTANT INFORMATION FOR YOU.
−
Keep this leaflet. You may need to read it
again.
−
If you have any further questions, ask your
doctor, or pharmacist.
−
This medicine has been prescribed for you
only. Do not pass it on to others. It may harm
them, even if their signs of illness are the
same as yours.
−
If you get any side effects, talk to your doctor,
or pharmacist. This includes any possible side
effects not listed in this leaflet.
WHAT IS IN THIS LEAFLET?
1. What Dicynone 250 is and what it is used for
2.
What
you
need
to
know
before
you
use
Dicynone 250
3. How to use Dicynone 250
4. Possible side effects
5. How to store Dicynone 250
6. Contents of the pack and other information
1. WHAT DICYNONE 250 IS AND WHAT IT IS USED FOR
PHARMACOTHERAPEUTIC CLASS
Other systemic haemostatic
Etamsylate is a synthetic antihaemorrhagic and
angioprotective drug acting on the first step of
haemostasis
(endothelium-platelet
interaction).
By improving platelet adhesiveness and restoring
capillary resistance, it is able to reduce bleeding
time and blood losses.
Etamsylate has no vasoconstrictor action, it does
not influence fibrinolysis nor modify the plasma
coagulation factors.
THERAPEUTIC INDICATIONS
_In surgery: _Prevention and treatment of pre-, per-
,
or
postsurgical
capillary
haemorrhages
in
all
delicate operations and in those affecting highly
vascularised
tissues:
E.N.T.,
gynaecology,
obstetrics,
urology,
odontostomatology,
ophthalmology,
plastic
and
reconstructive
surgery.
_In _
_paediatrics: _
Prevention
of
periventricular
haemorrhages in premature babies.
2.
WHAT
YOU
NEED
TO
KNOW
BEFORE
YOU
USE
DICYNONE 250
DO NOT USE DICYNONE 250:
- If you are allergic to the active substance or any
of the other ingredients of this medicine (listed in
section 6)
-
In
case
of
acute
porphyria
(an
illness
characterized
by
a
defect
in
the
synthesis
of
haemoglob